KR, I., KN, M., J, P., M, A., CB, L., L, Z., . . . P, C. (2022). Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways. Alzheimer's research & therapy, 14(1), 104. https://doi.org/10.1186/s13195-022-01044-1
Chicago Style (17th ed.) CitationKR, Ibanez, et al. "Deletion of Abi3/Gngt2 Influences Age-progressive Amyloid β and Tau Pathologies in Distinctive Ways." Alzheimer's Research & Therapy 14, no. 1 (2022): 104. https://doi.org/10.1186/s13195-022-01044-1.
MLA (9th ed.) CitationKR, Ibanez, et al. "Deletion of Abi3/Gngt2 Influences Age-progressive Amyloid β and Tau Pathologies in Distinctive Ways." Alzheimer's Research & Therapy, vol. 14, no. 1, 2022, p. 104, https://doi.org/10.1186/s13195-022-01044-1.